In the BioHarmony Drug Report Database

"Preview" Icon

Celecoxib

Celebrex, Elyxyb (celecoxib) is a small molecule pharmaceutical. Celecoxib was first approved as Celebrex on 1998-12-31. It is used to treat adenomatous polyposis coli, ankylosing spondylitis, dysmenorrhea, osteoarthritis, and rheumatoid arthritis in the USA. The pharmaceutical is active against prostaglandin G/H synthase 2. In addition, it is known to target carbonic anhydrase 12, prostaglandin G/H synthase 1, and carbonic anhydrase 2. Celebrex’s patent is valid until 2036-05-27 (FDA).

 

Trade Name

 

Celebrex, Elyxyb
 

Common Name

 

celecoxib
 

ChEMBL ID

 

CHEMBL118
 

Indication

 

adenomatous polyposis coli, ankylosing spondylitis, dysmenorrhea, osteoarthritis, rheumatoid arthritis
 

Drug Class

 

Cyclooxygenase-2 inhibitors

Image (chem structure or protein)

Celecoxib structure rendering